News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,615 Results
Type
Article (39609)
Company Profile (310)
Press Release (652696)
Section
Business (204866)
Career Advice (2012)
Deals (35498)
Drug Delivery (91)
Drug Development (81078)
Employer Resources (168)
FDA (16142)
Job Trends (14870)
News (345996)
Policy (32566)
Tag
Academia (2548)
Alliances (49598)
Alzheimer's disease (1294)
Approvals (16106)
Artificial intelligence (160)
Bankruptcy (356)
Best Places to Work (11622)
Biotechnology (217)
Breast cancer (205)
Cancer (1520)
Cardiovascular disease (121)
Career advice (1677)
CAR-T (107)
Cell therapy (312)
Clinical research (65035)
Collaboration (567)
Compensation (307)
COVID-19 (2565)
C-suite (132)
Data (1465)
Diabetes (187)
Diagnostics (6215)
Earnings (85148)
Employer resources (146)
Events (110850)
Executive appointments (474)
FDA (16911)
Funding (513)
Gene therapy (214)
GLP-1 (622)
Government (4352)
Healthcare (18759)
Infectious disease (2662)
Inflammatory bowel disease (118)
Interviews (309)
IPO (16421)
Job creations (3660)
Job search strategy (1430)
Layoffs (430)
Legal (7904)
Lung cancer (223)
Manufacturing (215)
Medical device (13242)
Medtech (13247)
Mergers & acquisitions (19332)
Metabolic disorders (492)
Neuroscience (1656)
NextGen: Class of 2025 (6542)
Non-profit (4483)
Northern California (1862)
Obesity (280)
Opinion (190)
Patents (133)
People (56949)
Phase I (20258)
Phase II (28647)
Phase III (21334)
Pipeline (611)
Postmarket research (2562)
Preclinical (8585)
Radiopharmaceuticals (239)
Rare diseases (283)
Real estate (5939)
Regulatory (21846)
Research institute (2319)
Resumes & cover letters (350)
Southern California (1612)
Startups (3618)
United States (16584)
Vaccines (579)
Weight loss (195)
Date
Today (25)
Last 7 days (429)
Last 30 days (1853)
Last 365 days (34955)
2025 (1600)
2024 (35368)
2023 (40181)
2022 (51290)
2021 (55835)
2020 (54156)
2019 (46645)
2018 (35125)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28771)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (203)
Asia (37597)
Australia (6151)
California (4235)
Canada (1549)
China (362)
Colorado (190)
Connecticut (203)
Europe (80549)
Florida (596)
Georgia (146)
Illinois (415)
Indiana (240)
Maryland (680)
Massachusetts (3271)
Michigan (182)
Minnesota (314)
New Jersey (1179)
New York (1198)
North Carolina (780)
Northern California (1862)
Ohio (154)
Pennsylvania (996)
South America (1096)
Southern California (1612)
Texas (613)
Utah (119)
Washington State (428)
692,615 Results for "caribou biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Business
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
Precision BioSciences, Inc. (Nasdaq: DTIL) today announced that it had granted Caribou Biosciences, Inc., a leading CRISPR genome-editing cell therapy company, a non-exclusive, worldwide license, with the right to sublicense, to one of Precision’s foundational cell therapy patent families for use with CRISPR in the field of human therapeutics.
February 20, 2024
·
7 min read
Press Releases
Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML
September 3, 2024
·
8 min read
Press Releases
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
January 14, 2025
·
1 min read
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
January 14, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
·
1 min read
1 of 69,262
Next
